|
End-of-day quote
Korea S.E.
16/10/2026
|
5-day change | 1st Jan Change | ||
| 4,705.00 KRW | +11.49% |
|
-13.99% | -31.61% |
| 09-21 | Genome & Company(KOSDAQ:A314130) added to S&P Global BMI Index | CI |
| 08-14 | Genome & Company Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| GENOME & COMPANY | Other Biotechnology & Medical Research | +11.49% | -13.99% | -31.61% | +67.74% | -74.11% | 164M |
-
|
-
|
-
|
- Stock Market
- Stocks
- A314130 Stock
- Charts Genome & Company
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
